Credit Suisse Ag Biogen Inc. Call Options Transaction History

Credit Suisse Ag

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $447,840 - $575,540	-2,000 Reduced 42.55%	2,700 $648,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $84,897 - $110,715	-300 Reduced 6.0%	4,700 $1.33 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $259,000 - $414,710	1,000 Added 25.0%	5,000 $1.73 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $4.35 Million - $5.09 Million	-17,900 Reduced 81.74%	4,000 $1.12 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $614,276 - $924,638	-2,600 Reduced 10.61%	21,900 $5.36 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $926,694 - $1.07 Million	-3,500 Reduced 12.5%	24,500 $6.95 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $3.23 Million - $4.28 Million	12,500 Added 80.65%	28,000 $7.49 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $12.9 Million - $16.3 Million	-47,900 Reduced 75.55%	15,500 $4.9 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $1.28 Million - $1.44 Million	5,900 Added 10.26%	63,400 $14.8 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $9.25 Million - $10.2 Million	42,200 Added 275.82%	57,500 $13.4 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $671,801 - $1.05 Million	3,100 Added 25.41%	15,300 $3.62 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $2.31 Million - $2.93 Million	-8,300 Reduced 40.49%	12,200 $3.67 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $18.1 Million - $21.3 Million	-64,500 Reduced 75.88%	20,500 $6.42 Million
Q2 2017 Aug 14, 2017	BUY	N/A	85,000	85,000 $23.1 Million

990

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.